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Abstract
Background: PRIMO is a dose verification system based on the general-purpose Monte Carlo radiation transport
code PENELOPE, which implements an accurate physics model of the interaction cross sections and the radiation
transport process but with low computational efficiency as compared with fast Monte Carlo codes. One of these fast
Monte Carlo codes is the Dose Planning Method (DPM). The purpose of this work is to describe the adaptation of DPM
as an alternative PRIMO computation engine, to validate its performance against PENELOPE and to validate it for some
specific cases.
Methods: DPM was parallelized and modified to perform radiation transport in quadric geometries, which are used
to describe linacs, thus allowing the simulation of dynamic treatments. To benchmark the new code versus PENELOPE,
both in terms of accuracy of results and simulation time, several tests were performed, namely, irradiation of a
multi-layer phantom, irradiation of a water phantom using a collimating pattern defined by the multileaf collimator
(MLC), and four clinical cases. The gamma index, with passing criteria of 1 mm/1%, was used to compare the absorbed
dose distributions. Clinical cases were compared using a 3-D gamma analysis.
Results: The percentage of voxels passing the gamma criteria always exceeded 99% for the phantom cases, with the
exception of the transport through air, for which dose differences between DPM and PENELOPE were as large as 24%.
The corresponding percentage for the clinical cases was larger than 99%. The speedup factor between DPM and
PENELOPE ranged from 2.5×, for the simulation of the radiation transport through a MLC and the subsequent dose
estimation in a water phantom, up to 11.8× for a lung treatment. A further increase of the computational speed, up to
25×, can be obtained in the clinical cases when a voxel size of (2.5 mm)3 is used.
Conclusions: DPM has been incorporated as an efficient and accurate Monte Carlo engine for dose estimation in
PRIMO. It allows the concatenated simulation of the patient-dependent part of the linac and the patient geometry in
static and dynamic treatments. The discrepancy observed between DPM and PENELOPE, which is due to an artifact of
the cross section interpolation algorithm for low energy electrons in air, does not affect the results in other materials.
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Background
PRIMO [1, 2] is a computer software that simulates clin-
ical linear accelerators (linacs) and estimates absorbed
dose distributions in phantoms and computerized tomog-
raphy (CT) studies. It combines a graphical user interface
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with the general-purpose radiation transportMonte Carlo
code PENELOPE (version 2011) [3]. It is freely distributed
through the website https://www.primoproject.net since
2013.
PENELOPE implements an accurate physics model of
the interaction cross sections and the radiation trans-
port process but exhibits a relatively low computational
performance compared with fast Monte Carlo codes
specifically designed for radiotherapy problems [4]. One
such code is the Dose Planning Method (DPM v1.1) [5]
which simulates absorbed dose distributions deposited by
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electron-photon showers in external beam radiotherapy
treatments. The open-source code is freely distributed
through http://www.upc.es/inte/downloads. The present
work describes the adaptation of DPM, hereafter identi-
fied as pDPM, to the PRIMO system and its subsequent
validation.
pDPM includes a mixed-geometry model that allows
the simulation in voxelized and quadric surface geome-
tries. This capability allows the joined simulation of the
linac patient-dependent part and the patient, hence mak-
ing possible the simulation of dynamic treatments. The
scope of including pDPM as a simulation engine of
PRIMO is to facilitate usage of the latter as a Monte
Carlo dose verification system for the routine clinical
practice.
Methods
The guidelines for reporting Monte Carlo simulations,
provided by the AAPM Task Group 268 [6], have been
followed in the preparation of this work.
Dose planningmethod
DPM gains in computing performance derive from vari-
ous enhancements to the description of particle transport
and of the underlying physics models. More precisely, the
main features that explain its accuracy and computational
efficiency are the following:
• It uses simplified cross section models that are
accurate for the energy range typically employed in
conventional radiotherapy and for low atomic
numbers, such as those encountered inside the
patient body. For example, the Klein-Nishina
differential cross section [7] is used to describe
photon incoherent (Compton) scattering, thus
neglecting Doppler broadening and binding effects,
which are non-negligible for high Z elements or low
energies. Similarly, the Møller differential cross
section [8] is used to describe electron inelastic
collisions with atomic electrons, thus assuming that
the target particle is free and at rest. This, again, is
valid for low atomic numbers and high energies.
• Photon transport is simulated detailedly using the
delta scattering, or Woodcock tracking technique [9],
which completely avoids the need to consider
intersections with voxel walls.
• For electrons, DPM employs the standard condensed
history model, falling into what has been called a
mixed scheme for the treatment of energy losses by
Berger [10]. It treats large energy transfer collisions
detailedly and uses the continuous slowing down
approximation to describe the effect of small energy
loss interactions. For condensing angular deflections,
the code is based on a refinement of the Kawrakow
and Bielajew [11] formulation of the Lewis multiple-
scattering theory [12], which allows fast random
sampling of the scattering angle. The algorithm
further relies on the small angle approximation,
under which all materials can be characterized by
means of a single scattering angle distribution.
The DPM code has been extensively benchmarked and
validated by a group from the University of Michigan
[13, 14]. It should be noticed that the bulk of the DPM
development effort was focused on the electron trans-
port algorithm. There is still room for improvement
regarding the application of variance-reduction tech-
niques for photon transport. Despite this fact, the code
has been shown to reproduce dose distributions esti-
mated with high-accuracy general-purpose Monte Carlo
codes within an error of the order of 1.5% of the max-
imum dose with a significant increase in computational
efficiency [15].
DPM has been employed as a dose distribution calcula-
tion engine by other authors. For example, version 3 beta
of the ADAC Pinnacle treatment planning system was
based on a C++ port of DPM. ADAC was subsequently
acquired by Philips Medical Systems in 2000 but the Pin-
nacle version based on DPM was never released [4]. The
code was also integrated into the University of Michi-
gan’s in-house treatment planning system (UMPlan) [15].
Additionally, a prototype of a new treatment planning
system based on DPM was also developed by Técnicas
Radiof ísicas (Zaragoza, Spain) [16].
Some researchers have devoted efforts to further accel-
erate the code. Thus, for instance, Tyagy and coworkers
[17] used the Message Passing Interface (MPI) library to
parallelize the algorithm,Weng et al. [18] aimed at vector-
izing the code and Jia et al. [19] adapted it to the graphics
processing unit (GPU) architecture.
DPM improvements
Parallelization of DPM
One of the limitations of DPM is its lack of support for
phase-space files or other sources of particles needed for
linac simulation. Furthermore, its sequential code cannot
fully exploit the capabilities of parallel processors. These
capabilities have been added to pDPM as explained in a
previous work [20].
Mixed geometrymodel
The developed mixed geometry model combines bodies
defined by quadric surfaces and voxels. The aim is to
merge the patient-dependent region of the linac, which is
modeled by quadrics, and the patient, represented by the
voxelized geometry. Therefore, in simulations of dynamic
treatments, the transport through both regions can be
performed in a single simulation step.
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In the mixed model the patient dependent region of the
linac is defined according to the rules of PENGEOM, the
PENELOPE geometry package, while the voxelized geom-
etry uses the model currently implemented in DPM. To
combine both models we rely on an approach that has
been used before by Sempau and collaborators in the
PENEASY code [2]. Transport in the voxelized geometry
proceeds as in the original version of DPM [21] while in
the quadric geometry it is performed using the routines
included in PENELOPE.
Dynamic geometry
Dynamic geometry uses our mixed geometry model to
simulate dynamic irradiations, thus allowing changing the
positions of multileaf collimators, jaws, gantry, collimator
and couch at execution time. To this purpose the sim-
ulation is divided into control points, each one defined
by a fixed configuration of the aforementioned movable
elements. The fraction of the total number of histories
that is simulated for each control point equals the fraction
of monitor units as specified in the cumulative meterset
weight of the DICOM-RTPLAN file.
Variance-reduction techniques
Two variance-reduction techniques [22] were imple-
mented in pDPM, namely simple particle splitting in the
patient and range-rejection of electrons in the internal
regions of the MLC and the jaws. Range rejection was
implemented through the movable-skins technique [23].
pDPM benchmarks
Simulations presented in this article considered a 6 MV
beam of a Clinac-iX linear accelerator equipped with
a Varian Millennium 120 MLC. The particle source
employed was a phase-space file (PSF) tallied from the
simulation of the patient-independent part of the linac
using PENELOPE with initial beam parameters E =
6.2 MeV, FWHME = 0.186 MeV, FWHMfocal spot size =
0.15 cm and a beam divergence of 2.5 degrees. The PSF
produces a dose distribution in water that reproduces well
the measured dose profiles.
The assessment of the agreement between dose distri-
butions was done using gamma analysis. The reference
data sets were those obtained with PENELOPE while the
evaluated data sets were those obtained with pDPM. Local
gamma analysis was performed with a search volume
established according to the distance to agreement (DTA)
criterion. The maximum search distance from the refer-
ence point to the volume border is calculated as 1.2DTA.
Therefore, any evaluated dose point outside the local vol-
ume cannot pass the gamma analysis as it would not
comply with the DTA criterion. The search step inside the
local volume is set such that at least 5 points are sam-
pled in each spatial direction inside the volume and it is
required to be at least half the minimum spatial resolu-
tion of both dose distributions. Dose sampling inside the
local volume is made by tri-linear interpolation. Reference
dose values less than 1% of the maximum dose or with
uncertainties (2σ ) larger than 10% were not included in
the analysis. Gamma pass rate (d,DTA), i.e. the fraction of
points passing gamma analysis with a dose difference d (in
%) and distance DTA (in mm) criteria was evaluated in all
cases. For clinical cases, 1,1, 2,1 and 2,2 were evaluated
in the region inside the patient’s body, in planning target
volumes (PTVs) and in selected organs-at-risk (OARs).
Additionally, the method proposed by Kawrakow and
Fippel [24] was used to compare the dose distributions
estimated with PENELOPE and pDPM. This method
allows to discern systematic differences from those result-
ing from statistical fluctuations. In all clinical cases, the
dose threshold applied was 50% of the maximum dose
and only voxels inside the patient’s body region were con-
sidered. For simulations in phantoms the dose threshold
applied was 20% of the maximum dose.
Photon transport in aMLC
Dose distributions produced by a 6MVphoton beamwere
estimated with pDPM and PENELOPE. The Varian Mil-
lennium 120 MLC was configured with the leaf pattern
represented in Fig. 1. This pattern, the same used byHeath
and coworkers [25], was chosen because it can assess the
effect on the dose of several critical regions of the MLC in
a single simulation. The dose distributions were tallied in
a water phantom of 40 × 40 × 30 cm3 with a bin size of
0.2×0.2×0.5 cm3. The field size was set to 30×40 cm2. A
total of 109 histories were simulated to obtain an average
standard statistical uncertainty of 0.2%. The evaluation
was made by gamma analysis and also by comparing dose
profiles taken along critical regions.
Photon transport in amulti-layer phantom
Dose distributions produced by a 6MVphoton beamwere
estimated in a slab phantom consisting of seven 5-cm-
thick layers. The phantom dimensions were 40 × 40 ×
35 cm3 with a bin size of 0.5 × 0.5 × 0.25 cm3. An open
field of 10 × 10 cm2 with a SSD = 100 cm was used. The
layer materials were (starting from the upstream phan-
tom surface): muscle skeletal (ρ = 1.04 g/cm3), air, lung
(ρ = 0.3 g/cm3), muscle skeletal, compact bone (ρ =
1.85 g/cm3), lung and muscle skeletal [26].
Simulation of photon beams in clinical cases
Three volumetric-modulated arc therapy (VMAT) clinical
cases of head and neck, brain and lung were consid-
ered in this work. The head and neck plan consisted of
two coplanar hemi-arcs, covering from 0 to 179 degrees.
Each arc had 96 control points. Two PTVs were delin-
eated in the left side of the patient neck (see Fig. 4). The
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Fig. 1 Leaf pattern used to verify the transport through the MLC. Dose
profiles were taken in the water phantom along the dashed lines
prescribed dose were 40 Gy and 44 Gy in 20 fractions to
PTV1 and PTV2, respectively. Two OARs were selected
for dose comparison, the left parotid gland and the spinal
cord. The lung plan also had two hemi-arcs, from 181 to 0
degrees with 96 control points each. The PTV was a rela-
tively small region with a volume of 6.9 cm3 located in the
posterior lung wall near the diaphragm. The prescribed
dose to that PTV was 52 Gy in 8 fractions. The brain case
is a post surgery irradiation of a brain tumor. Two PTV
regions were delimited PTV1 and PTV2 with prescribed
doses of 50 Gy and 60 Gy in 25 fractions, respectively. The
plan consisted of two coplanar full arcs with 177 control
points each. The brain stem OAR was selected for dose
comparison. Additionally, a prostate IMRT plan consist-
ing of five fields distributed at angles of 255, 315, 45, 105
and 180 degrees was included in this study. The total num-
ber of control points was 621. The prescribed dose to the
prostate PTV was 76 Gy in 39 fractions. The bladder and
rectum OARs were selected for dose comparison.
The voxelized geometry generated by PRIMO uses the
voxel size provided in the CT scan. However, PRIMO
allows to set a fixed spatial resolution of the simulation
geometry of 0.25 cm3. This is done by averaging HU
in neighbor voxels, each weighted by the fraction of the
volume included in the destination voxel. At the end of
the simulation the original CT resolution is recovered by
interpolating the dose obtained for the coarser voxel size.
Dose distributions were obtained with pDPM, both
using the original voxel size and the coarse option, and
with PENELOPE only using the original size. The dose dis-
tribution obtained with the original CT resolution was
used for comparison with PENELOPE. Gamma analysis
was applied to all voxels inside the body region.
Simulation times
Simulation times obtained with pDPM were reported in a
previous work [20]. However, that article considered only
voxelized geometries. For the present study all simulations
were carried out in two Xeon E5-2670V3 CPUs with 12
cores each, and hyper-threading. The compiler used was
Intel Fortran v16 for Windows with compilation options
/O2 /Qipo /QxP for PENELOPE and /Qopenmp for
pDPM. PENELOPE is a serial code, hence, simulations were
carried out by simultaneously running 32 instances of
the code (each one with different initial random number
seeds) and letting the operating system (Windows Server
2016) deal with the task assignment to the CPU cores. In
order to provide a source of particles for each PENELOPE
instance, the source phase-space file must be partitioned
prior to starting the simulation. For the phase space used
in this work this partitioning process took approximately
15min. This timewas not taken into account in the bench-
mark. Conversely, pDPMgenuinely runs in parallel, hence,
partitioning of the phase-space file is not necessary. The
simulations with pDPM used 32 threads. In all cases the
simulation time reported corresponds to that required to
reach an average standard statistical uncertainty of 1%.
The reported dose statistical uncertainties are computed
using voxels that score more than 50% of the maximum
dose.
Results
Photon transport in a MLC
A good agreement between the dose distributions
obtained with PENELOPE and pDPMwas obtained for this
test. The percentage of points passing gamma analysis
with criteria of 1%, 1mmwas 99.5%. Systematic deviations
between both dose distributions are small as depicted in
Table 1. The good agreement between both distributions
can also be observed in the dose profiles shown in Fig. 2.
The dose profiles in Fig. 2a were taken in the direction
of the x-axis at y = 0 at a depth of 5 cm. From Fig. 1
it can be observed that the dose in this region is mainly
produced by radiation traversing the tongue and groove
region of the two central leaves. The peak at the center
of the profile is produced by radiation traversing the gap
between the two opposed rounded leaf tips. Figure 2b rep-
resents profiles taken along the x-axis direction at off-axis
y = 6.25 cm and 5 cm of depth. They correspond to
the transition from the tongue and groove region to an
open field, including the effect of the leaf tips. Figure 2c
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Table 1 Systematic differences between the dose distributions estimated with PENELOPE and pDPM for the photon test cases included
in this work
Test case α [%] [ %] α[ %] [ %]
Described in section Photon transport in amulti-layer phantom
(all voxels) 14.2 -5.0 17.0 0.2
(in the air layer) 97.0 -5.3 0 0
(excluding the air layer) 32.1 -0.2 20.4 0.2
Described in “Photon transport in a MLC” section 26.0 -0.4 13.3 0.3
Head&Neck 32.4 -0.8 17.8 0.7
Lung 36.6 -0.8 11.7 0.5
Brain 30.5 -0.6 7.0 0.7
Prostate 28.1 -0.4 18.2 0.4
They are expressed as the percentage of voxels α with a systematic deviation  given in percentage of the maximum dose
represents profiles taken along the y-axis at 5 cm of depth
and x = 0. Figure 2d are depth dose curves taken at
the central axis, with a main contribution from radiation
traversing the gap between the tips of the central leaves.
In all profiles the dose difference between PENELOPE and
pDPM is lower than 1% of the PENELOPE maximum dose
except for the first 0.5 cm of the build-up region where the
statistical uncertainty is too large to say. The larger statis-
tical uncertainty in the build-up is due to the presence of
contaminant electrons in the beam.
Fig. 2 Dose profiles produced with simulations employing pDPM and PENELOPE of a 6 MV photon beam and the MLC configured according to the
pattern in figure 1. The profiles were taken along critical dose regions. Dose uncertainties are plotted only when they are larger than symbols. Dose
differences PENELOPE−pDPM relative to the PENELOPE maximum dose are shown in green
Rodriguez et al. Radiation Oncology          (2018) 13:256 Page 6 of 9
Photon transport in a multi-layer phantom
The depth dose curve at the central axis of the phantom is
shown in Fig. 3. Uncertainties are only shown in the region
filled with air. In that region the average standard uncer-
tainty is 1.7%. In the remaining regions it is 0.3%. Good
agreement between the profile obtained with pDPM and
PENELOPE is observed except for the region filled with air.
The agreement between both profiles is better than 1%
except for air, where themaximumdifference is 24%. From
Table 1 it can be seen that systematic differences in the
region filled with air range between 5 − 6%.
Simulation of photon beams in clinical cases
Combined standard uncertainties obtained for the simu-
lations of clinical cases with PENELOPE and pDPM were
0.60, 0.77, 0.63 and 0.7 for brain, head and neck, lung and
prostate, respectively. In all cases, a good match between
both dose distributions was obtained. The fraction of
points passing the 3-D gamma analysis inside the body
region with criteria of 1%, 1 mm (1,1) were 99.7%, 99.6%,
99.8% and 99.6%, for the cases of brain, head and neck,
lung, and prostate, respectively. Table 2 shows gamma
pass rates 1,1 and 2,1 for PTVs and selected OARs. A
good agreement was obtained in all cases except for 1,1
of the head and neck PTV2 probably due to its small vol-
ume (50 cm3) and the fact that 1% dose difference is in the
range of the average dose uncertainty. However, when the
dose difference criterion is set to 2%, gamma pass rate is
100% for that PTV. Figure 4 shows a PRIMO screenshot
Fig. 3 Depth dose curve for PENELOPE and pDPM at central axis of a
multi-material slab phantom. Dose uncertainties are plotted only for
the air, for the rest of materials they are smaller than symbols. Dose
differences PENELOPE−pDPM relative to the PENELOPE maximum dose
are shown in green
Table 2 Fraction of points passing gamma analysis with criteria
1%, 1 mm (1,1) and 2%, 1 mm (2,1) in the region delimited by
the body contour, the PTVs and the OARs
Region 1,1 [%] 2,1 [%]
Prostate
Body 99.8 100
PTV 99.6 100
Rectum 99.7 100
Bladder 100 100
H&N
Body 99.6 100
PTV1 98.0 100
PTV2 96.2 100
Spine 100 100
Left Parotid 99.2 99.9
Brain
Body 99.7 100
PTV1 99.4 100
PTV2 99.1 100
Brain stem 99.6 100
Lung
Body 99.6 100
PTV 99.2 100
with the comparison for the head and neck case. System-
atic differences were small, within±0.8% of the maximum
dose for all cases.
Simulation times
Results of the performance benchmark for mixed geome-
tries are shown in Table 3. It can be observed that the
speedup of pDPM with respect to PENELOPE is moder-
ate. The pDPM computational speed is hampered by the
fact that the transport through the linac uses the PENE-
LOPE geometry model. Furthermore, the time employed
in updating the quadric geometry in dynamic plans is
roughly 0.4 s per control point. A more favorable simula-
tion time is obtained when the “coarse” option is used in
pDPM, as it is shown in the “coarse voxel” column.
Discussion and conclusions
DPM has been incorporated as an efficient Monte Carlo
engine for photon dose estimation in PRIMO since ver-
sion 0.3.1.1600. It allows the joined simulation of the
patient-dependent part of the linac and the patient geom-
etry, thus facilitating dose estimation of dynamic treat-
ments. The version of PRIMO used for this article has
been 0.3.1.1681.
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Fig. 4 PRIMO screenshot showing the results of 3-D gamma analysis, performed with criteria 1%, 1 mm, for the head and neck case in which
PENELOPE and pDPM simulations are compared. An excellent agreement, of 99.6%, between both simulations is obtained. The dose-volume
histograms of the PTVs, whose contours appear in the upper panels, have been magnified to better expose the small differences between pDPM
(solid lines) and PENELOPE (dashed lines)
PENELOPE and DPM use different physics models. Gen-
erally speaking, DPM cross section models are simpler
albeit accurate enough for the dynamical range for which
the code was designed, that is, low Z materials and high
energies. In this work, however, we have used pDPM
to simulate the transport in some of the tungsten ele-
ments of the linac head. Despite this fact, the comparisons
between PENELOPE and pDPMmade in this work have not
shown a substantial impact on the dose accuracy of DPM
physics models simplifications. Thus, a good agreement
between the results obtained with PENELOPE and pDPM
was obtained for the studied clinical cases, in which 99.9%
or more of points passed the 3-D gamma analysis with
criteria 2%, 1 mm and systematic differences were within
Table 3 Simulation times in minutes for PENELOPE and pDPM to obtain a dose distribution with 1% standard statistical uncertainty for
some single field cases and dynamic treatments
Simulation time [min] Speedup
pDPM
Test case Voxel size
[
cm3
]
PENELOPE Original voxel Coarse voxel Original voxel Coarse voxel
Described in “Photon transport in a
multi-layer phantom” section
0.5 × 0.5 × 0.25 37 9.5 - 3.9× -
Described in “Photon transport in a MLC”
section
0.2 × 0.2 × 0.5 324 129 - 2.5× -
Head&Neck VMAT, 194 CP 0.19 × 0.15 × 0.19 1061 140 42 7.6× 25.3×
Lung VMAT, 194 CP 0.19 × 0.14 × 0.19 331 28 14 11.8× 23.6×
Brain VMAT, 354 CP 0.11 × 0.2 × 0.11 687 117 34 5.8× 20.2×
Prostate IMRT, 621 CP 0.18 × 0.25 × 0.18 472 64 45 7.3× 10.5×
Clinical cases were simulated with the same voxel size of the original CT scan (original voxel), for both PENELOPE and pDPM. Simulation times with pDPM for the clinical cases
in which the coarse voxel size of (0.25 cm)3 was employed are reported in the corresponding column. The speedups of pDPM with respect to PENELOPE for the simulation
with the original voxel size are given in the Original voxel column. The speedup obtained with the coarse option of pDPM is also reported. CP stands for control point
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±0.8% of the maximum dose. The discrepancy observed
in the multi-layer phantom, related to the transport in
air, is due to an artifact of the cross section interpolation
algorithm for low energy electrons in air. The dose is not
biased in any other material, nor at the interfaces with
air. Investigations to correct this artifact are currently in
progress.
The speedup factor obtained with pDPM with respect
to PENELOPE was in all clinical cases between 6 and 12.
This speedup factor is further increased when voxels are
grouped using the “coarse” option, attaining values in the
order of 20. These factors are reached although the trans-
port in the linac geometry hinders the overall efficiency of
pDPMowing to the use of the PENELOPE geometrymodel.
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